Survey finds stress levels for many are higher now than during height of the pandemic.
The COVID-19 pandemic has abated, but its influence on the mental health of doctors and their patients lingers, and in some ways has gotten worse, according to results of a new survey.
Medical software producer AdvancedMD recently queried 200 of its customers—independent practice owners and physicians—about their own mental health and that of their patients. Among the results:
Asked about the sources of their work-related stress, 40% cited “daily responsibilities,” 31% named staffing shortages and 29% said increased patient volumes.
In a statement, Advanced MD President Amanda Hansen, called the survey results “startling.”
“The fact that stress levels have increased during the last three years for patients and the health care providers who take care of them underscores just how big of an issue behavioral health is within the health care industry and the patient populations we serve,” Hansen said.
The survey also revealed that, contrary to the advice usually offered to patients, only 15% of physician respondents said they used behavioral health therapy to manage stress.
“Behavioral health care providers will be the first to tell you that talking about stress—what’s causing it, how it is affecting your life, and all the ways it manifests during your day—is the first step to addressing mental health issues,” Hansen said. “We conducted this survey not only to better understand how stress was showing up in ambulatory care practices but also to begin a discussion with AdvancedMD users about their own stress levels.”
This article was published by our sister publication Medical Economics.
Physical intimate partner violence linked to decreases in cognitive performance
September 10th 2024A study presented at the 2024 Annual Meeting of The Menopause Society, found that women who reported physical intimate partner violence also demonstrated decreased working memory performance over time.
Read More
Contemporary OB/GYN Senior Editor Angie DeRosa gets insight on the current state of COVID-19 from Christina Han, MD, division director of maternal-fetal medicine at the University of California, Los Angeles, and member of its COVID-19 task force. Han is an active member of the Society for Maternal-Fetal Medicine and discusses the issues on behalf of SMFM.
Listen
First patient dosed in RECONNECT trial of RE104 for postpartum depression
July 23rd 2024Reunion Neuroscience Inc. initiates phase 2 trial of RE104, a novel short-duration psychedelic treatment for postpartum depression, aiming to provide rapid and effective relief for affected mothers.
Read More